161 related articles for article (PubMed ID: 16623650)
1. Immunotherapy of neuroblastoma: present, past and future.
Raffaghello L; Pistoia V
Expert Rev Neurother; 2006 Apr; 6(4):509-18. PubMed ID: 16623650
[TBL] [Abstract][Full Text] [Related]
2. [Rational bases for new approaches to the therapy of pediatric solid tumors: immunotherapy and gene therapy].
Pistoia V; Prigione I; Facchetti P; Corrias MV
Pediatr Med Chir; 1994; 16(3):219-25. PubMed ID: 7971443
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for neuroblastoma: turning promise into reality.
Gray JC; Kohler JA
Pediatr Blood Cancer; 2009 Dec; 53(6):931-40. PubMed ID: 19591222
[TBL] [Abstract][Full Text] [Related]
4. Antibody-based immunotherapy in high-risk neuroblastoma.
Johnson E; Dean SM; Sondel PM
Expert Rev Mol Med; 2007 Dec; 9(34):1-21. PubMed ID: 18081947
[TBL] [Abstract][Full Text] [Related]
5. Disialoganglioside directed immunotherapy of neuroblastoma.
Modak S; Cheung NK
Cancer Invest; 2007 Feb; 25(1):67-77. PubMed ID: 17364560
[TBL] [Abstract][Full Text] [Related]
6. [Neuroblastoma: diagnosis and therapy].
Wargalla-Plate U; Hero B; Berthold F
Praxis (Bern 1994); 1995 Oct; 84(41):1152-7. PubMed ID: 7481325
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy of poor-prognosis neuroblastoma in children: from bench to bedside].
Rousseau R; Combaret V; Yvon E; Schell M; Philip I; Puisieux A; Frappaz D; Philip T; Bergeron C
Bull Cancer; 2006 Feb; 93(2):153-61. PubMed ID: 16517413
[TBL] [Abstract][Full Text] [Related]
8. Pediatric CNS tumors: current treatment and future directions.
Hargrave DR; Zacharoulis S
Expert Rev Neurother; 2007 Aug; 7(8):1029-42. PubMed ID: 17678498
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of neuroblastoma.
George RE; Diller L; Bernstein ML
Expert Opin Pharmacother; 2010 Jun; 11(9):1467-78. PubMed ID: 20408767
[TBL] [Abstract][Full Text] [Related]
10. Embryonal neural tumours and cell death.
Johnsen JI; Kogner P; Albihn A; Henriksson MA
Apoptosis; 2009 Apr; 14(4):424-38. PubMed ID: 19259824
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma: biology, prognosis, and treatment.
Park JR; Eggert A; Caron H
Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma: current status of immunotherapy and future trends (Review).
Mori K; Rédini F; Gouin F; Cherrier B; Heymann D
Oncol Rep; 2006 Mar; 15(3):693-700. PubMed ID: 16465432
[TBL] [Abstract][Full Text] [Related]
13. CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma.
Miles SA; Sandler AD
Adv Drug Deliv Rev; 2009 Mar; 61(3):275-82. PubMed ID: 19186194
[TBL] [Abstract][Full Text] [Related]
14. Ten challenges in the management of neuroblastoma.
Gains J; Mandeville H; Cork N; Brock P; Gaze M
Future Oncol; 2012 Jul; 8(7):839-58. PubMed ID: 22830404
[TBL] [Abstract][Full Text] [Related]
15. Glioma immunology and immunotherapy.
Parney IF; Hao C; Petruk KC
Neurosurgery; 2000 Apr; 46(4):778-91; discussion 791-2. PubMed ID: 10764250
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy shows promise in Phase III neuroblastoma trial.
Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644467
[No Abstract] [Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
[TBL] [Abstract][Full Text] [Related]
19. Toward a glioblastoma vaccine: promise and potential pitfalls.
Fine HA
J Clin Oncol; 2004 Nov; 22(21):4240-3. PubMed ID: 15452184
[No Abstract] [Full Text] [Related]
20. Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cells.
Carlson LM; Påhlman S; De Geer A; Kogner P; Levitskaya J
Cell Res; 2008 Mar; 18(3):398-411. PubMed ID: 18268541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
